Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial.
Breast Cancer Res Treat · 2025-Jul · PMID 40293644
OS
Fig. 1 Kaplan Meier curves for survival endpoints unadjusted for patient and disease characteristics. Time, in years, is measured from date of randomization; Twenty-five patients (5.9%) started statin treatment after randomization (median time from randomization to treatment start, 2.3 months; IQR, 2 days–6.6 months). Overall about 95% of statin users were under treatment at randomization (91%) or started within 3 months after randomization (4%). Two patients started statin treatment after 1 year from randomization and were considered non-statin users. Results landmarked from 12 months after study enrolment, and those based on a time-varying Cox model analysis were similar to those depicted in this analysis measured from date of randomization. CI confidence interval, DRFI distant relapse-free interval, HR hazard ratio, IDFS invasive disease-free survival, No. number, OS overall survival
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.2722 | 0.0000 | 26.5432 | 87 | 115 |
| 1 | 2 | 0.0813 | 0.2722 | 0.4880 | 26.5432 | 104 | 115 |
| 1 | 3 | 0.0861 | 0.2722 | 0.5167 | 26.5432 | 105 | 115 |
| 1 | 4 | 0.0909 | 0.2722 | 0.5455 | 26.5432 | 106 | 115 |
| 1 | 5 | 0.0957 | 0.2722 | 0.5742 | 26.5432 | 107 | 115 |
| 1 | 6 | 0.1005 | 0.2722 | 0.6029 | 26.5432 | 108 | 115 |
| 1 | 7 | 0.1053 | 0.2722 | 0.6316 | 26.5432 | 109 | 115 |
| 1 | 8 | 0.1100 | 0.2722 | 0.6603 | 26.5432 | 110 | 115 |
| 1 | 9 | 0.1148 | 0.2722 | 0.6890 | 26.5432 | 111 | 115 |
| 1 | 10 | 0.1196 | 0.2722 | 0.7177 | 26.5432 | 112 | 115 |
| 1 | 11 | 0.1244 | 0.2722 | 0.7464 | 26.5432 | 113 | 115 |
| 1 | 12 | 0.1292 | 0.2722 | 0.7751 | 26.5432 | 114 | 115 |
| 1 | 13 | 0.1340 | 0.2722 | 0.8038 | 26.5432 | 115 | 115 |
| 1 | 14 | 0.1388 | 0.2722 | 0.8325 | 26.5432 | 116 | 115 |
| 1 | 15 | 0.1435 | 0.2722 | 0.8612 | 26.5432 | 117 | 115 |
| 1 | 16 | 0.1483 | 0.2722 | 0.8900 | 26.5432 | 118 | 115 |
| 1 | 17 | 0.1531 | 0.2722 | 0.9187 | 26.5432 | 119 | 115 |
| 1 | 18 | 0.1579 | 0.2722 | 0.9474 | 26.5432 | 120 | 115 |
| 1 | 19 | 0.1627 | 0.2722 | 0.9761 | 26.5432 | 121 | 115 |
| 2 | 1 | 0.0000 | 0.1329 | 0.0000 | 12.9630 | 87 | 137 |
| 2 | 2 | 0.0861 | 0.1329 | 0.5167 | 12.9630 | 105 | 137 |
| 2 | 3 | 0.0909 | 0.1329 | 0.5455 | 12.9630 | 106 | 137 |
| 2 | 4 | 0.0957 | 0.1329 | 0.5742 | 12.9630 | 107 | 137 |
| 2 | 5 | 0.1005 | 0.1329 | 0.6029 | 12.9630 | 108 | 137 |
| 2 | 6 | 0.1053 | 0.1329 | 0.6316 | 12.9630 | 109 | 137 |
| 2 | 7 | 0.1100 | 0.1329 | 0.6603 | 12.9630 | 110 | 137 |
| 2 | 8 | 0.1148 | 0.1329 | 0.6890 | 12.9630 | 111 | 137 |
| 2 | 9 | 0.1196 | 0.1329 | 0.7177 | 12.9630 | 112 | 137 |
| 2 | 10 | 0.1244 | 0.1329 | 0.7464 | 12.9630 | 113 | 137 |
| 2 | 11 | 0.1292 | 0.1329 | 0.7751 | 12.9630 | 114 | 137 |
| 2 | 12 | 0.1340 | 0.1329 | 0.8038 | 12.9630 | 115 | 137 |
| 2 | 13 | 0.1388 | 0.1329 | 0.8325 | 12.9630 | 116 | 137 |
| 2 | 14 | 0.1435 | 0.1329 | 0.8612 | 12.9630 | 117 | 137 |
| 2 | 15 | 0.1483 | 0.1329 | 0.8900 | 12.9630 | 118 | 137 |
| 2 | 16 | 0.1531 | 0.1329 | 0.9187 | 12.9630 | 119 | 137 |
| 2 | 17 | 0.1579 | 0.1329 | 0.9474 | 12.9630 | 120 | 137 |
| 2 | 18 | 0.1627 | 0.1329 | 0.9761 | 12.9630 | 121 | 137 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-24T15:18:10+00:00 |